Complications of ERCP for choledocholithiasis in a sickle cell cohort

• Published in: Tropical doctor Vol. 45; no. 1; p. 15
• Main Authors: Cawich, Shamir O, Arthurs, Milton, Murphy, Trevor, Bonadie, Kimon O, Roberts, Hugh A, Naraynsingh, Vijay
• Format: Journal Article
• Language: English
• Published: England 01.01.2015
• Subjects: Adolescent; Adult; Aged; Anemia, Sickle Cell; Cholangiopancreatography, Endoscopic Retrograde - adverse effects; Choledocholithiasis - complications; Choledocholithiasis - surgery; Female; Humans; Male; Middle Aged; Pancreatitis - complications; Pancreatitis - surgery; Pneumonia; Postoperative Complications - mortality; Retrospective Studies; Treatment Outcome; Trinidad and Tobago - epidemiology; Trinidad and Tobago; ERCP; pancreatitis; morbidity; acute chest syndrome; sickle cell disease
• ISSN: 1758-1133
• DOI: 10.1177/0049475514552550

Patients with sickle cell disease (SCD) demand special attention during clinical interventions because they are predisposed to acute chest syndrome (ACS), vaso-occlusive crises, intra-vascular haemolysis and immune paresis. Although SCD is endemic in the Caribbean, there has been no report on endoscopic retrograde cholangio-pancreatography (ERCP) outcomes in these patients from this region. The records of patients with SCD who underwent ERCP between 1 January 2005 and 1 June 2010 were analysed retrospectively. Parameters assessed included patient demographics, procedural details, ERCP-related and SCD-related morbidity. Data were analysed using SPSS version 12.0. Fifty-four patients with SCD were subjected to ERCP during the study period. There were 37 women and 17 men at a mean age of 28 years (SD +/-12.05). There was 29% (16) overall morbidity, with 10 (18.5%) SCD-related complications and six (11.1%) ERCP-specific complications. More common complications were: pancreatitis (9.3%); cholangitis (1.9%); ACS (9.3%); pneumonia (3.7%); and painful crises (5.6%). There was one death (1.9%) due to multiple organ failure secondary to severe pancreatitis. This study suggests that the SCD cohort requires special perioperative attention to minimise the inordinately high morbidity, many of which are SCD-related. We propose a perioperative management protocol that may minimise morbidity in these patients.